In 2007, it was selected as one of the top ten innovative state-owned enterprises in Beijing. Product No. 0 was selected into the top ten independent innovation brands of Beijing state-owned enterprises.

Selected as Beijing Harmonious Labor Relations Unit.

Selected as China’s rights protection, trustworthy and honest enterprise. In 2006, it was selected as the National Outstanding Integrity Enterprise. Selected as a national outstanding independent innovation enterprise. Selected as one of the top ten meritorious enterprises in the capital. Selected as an outstanding unit for ideological and political work in Beijing. Anhui Shuanghe was selected as an enterprise with excellent pharmaceutical production management and efficiency in Anhui Province. In 2005, the company further focused on the three major fields of general infusion, cardiovascular and cerebrovascular, and endocrinology, and its core products in these three categories maintained a growth rate of 10.67%. The overall operating performance has surpassed the best level in history, with main operating income reaching 4.6 billion yuan and net profit reaching 187 million yuan that year.

Selected as one of the top ten most profitable enterprises in key industries nationwide, ranking fifth in the chemical pharmaceutical manufacturing industry.

Selected into the top 100 pharmaceutical companies in China, ranking tenth.

Selected into the top 100 Chinese corporate websites, ranking 44th.

Selected as the most growing independent brand enterprise in China's manufacturing industry.

Selected as an advanced enterprise for economic and technological innovation in Beijing.

Selected as an advanced unit of the Capital Employee Quality Education Project.

Anhui Shuanghe was awarded the Anhui Provincial Quality Management Award by the Provincial State-owned Assets Supervision and Administration Commission and the Provincial Quality Management Association.

Changsha Shuanghe Pharmaceutical was selected as a contract-abiding and trustworthy enterprise in Hunan Province.

Tangshiping products were selected as the preferred brand for consumer satisfaction with diabetes medication in China.

Erythromycin cycloester (Guansha) obtained the national Torch Plan project certificate. In 2004, it was selected into the top 100 enterprises in Beijing.

Changsha Shuanghe Pharmaceutical was selected as an honest pharmaceutical commercial enterprise in Hunan Province.

Changsha Shuanghe Pharmaceutical was selected as a contract-abiding and trustworthy enterprise in Hunan Province.

No. 0 and Tang Shiping were selected as Beijing famous brand products for the first time.

No. 0 sales exceeded 700 million pieces, a record high.

Shenlu Shuanghe’s sales revenue and total profit both entered the top 100 in the country’s traditional Chinese medicine industry for the first time. In 2003, it was selected into the top 100 leading companies in the competitiveness index of listed companies.

Selected into the Top 500 Chinese Enterprises in Information Technology.

Selected into the first batch of trustworthy enterprises in Beijing.

Shuanghe Research Institute was selected as the Beijing Municipal Enterprise Technology Center.

Anhui Shuanghe was rated as an important backbone enterprise for foreign investment by the provincial government; in the same year, it was rated as a Class A advanced unit for honest tax payment by the Anhui Provincial State Taxation Bureau.

Changsha Shuanghe Pharmaceutical was selected as an honest pharmaceutical commercial enterprise in Hunan Province.

Jinxin Shuanghe was selected as a national contract-abiding and credit-worthy enterprise.

Lifusun Injection won the National Torch Plan Project Certificate. In 2002, the main operating income exceeded 2 billion yuan for the first time, and the profit reached 168 million yuan.

Selected into the top 500 Chinese enterprises.

Selected as a constituent stock of Shanghai Stock Exchange 180 Index.

Selected as one of the top twenty enterprises in Zhongguancun Science and Technology Park Electronic City Science and Technology Park.

Selected as an advanced quality enterprise in Beijing.

For the first time, it was selected as a famous brand product manufacturer in Beijing.

Won the Beijing Excellent Enterprise Management Award.

For the first time, it was selected as an “A” grade enterprise in Beijing.

Shuanghe Operating Company was selected into the top 100 sales of national pharmaceutical commercial enterprises, ranking 49th.

Shenlu Shuanghe was selected as a high-tech enterprise in Anhui Province.

Binhu Shuanghe won the "AAA" credit rating certificate for the third time.

Hunan Shuanghe Pharmaceutical was selected as one of the top 100 enterprises in Hunan Province.

Binhu Shuanghe was selected as an enterprise that abides by contracts and keeps promises in Hubei Province.

Anhui Shuanghe won the title of High-tech Enterprise in Anhui Province.

Li Fuxing series won the Beijing High-Tech Achievements Transformation Project Certification Certificate. In 2001, it was selected as an advanced enterprise for economic and technological innovation in Beijing for the first time.

Selected as one of the six model enterprises for the restructuring of state-owned enterprises in Beijing.

Won the title of “National Excellent Enterprise in Ideological and Political Work in the Pharmaceutical Industry”.

Being rated as "Advanced Enterprise in Achieving State-owned Enterprise Reform and Eradication from Poverty".

Being named the Capital Civilized Unit in 2000-2001.

The trademarks "Double Crane (picture)" and "Ao Fuxing" were selected as famous trademarks in Beijing for the first time, becoming one of the few companies in Beijing with two famous trademarks at that time.

"Shuanghe (picture)" and new drugs, patent medicines, capsules, capsules, and raw materials were selected as famous trademarks in Beijing for the first time.

The sales revenue of "No. 0" single product exceeded 200 million yuan for the first time. In 2000, it was selected as an advanced enterprise in total quality management.

Selected as an advanced enterprise for economic and technological innovation in Beijing.

Rated as a user-satisfying enterprise in Beijing.

Winning enterprise in Beijing’s “Ankang Cup” competition.

The main products Zengyiliansulfon Tablets, Aofuxing series and Lifuxing series were selected as Beijing famous brand products for the first time.

The research on the main product Lifusun series won the second prize of Beijing Science and Technology Progress Award.

The production and sales revenue of the main products No. 0, large infusion series, Lifusing series, and sulfamethoxazole API exceeded 100 million yuan. In 1999, it was selected as a national outstanding pharmaceutical enterprise.

Selected as a civilized unit in the capital.

Won the Beijing Excellent Enterprise Management Award. In 1997, the production and sales of key products Aofuxing series, synergistic sulfonate tablets, infusion solutions, and No. 0 continued to grow. In that year, the main operating income was 236 million yuan and the net profit was 47 million yuan.